Literature DB >> 20093375

Helicobacter pylori antibiotic resistance and [13C]urea breath test values.

Vincenzo De Francesco1, Angelo Zullo2, Federico Perna3, Floriana Giorgio1, Cesare Hassan2, Lucy Vannella1, Francesca Cristofari2, Carmine Panella1, Dino Vaira3, Enzo Ierardi1.   

Abstract

A correlation between delta over baseline (DOB) values of the [(13)C]urea breath test (UBT) and Helicobacter pylori clarithromycin resistance has been reported, suggesting a possible predictive role of UBT in therapeutic outcome. However, available data are limited and conflicting. This study aimed to clarify this issue, assessing the possible relationship between H. pylori resistance towards different antibiotics (clarithromycin, metronidazole and levofloxacin) and UBT values. The data showed similar DOB values between susceptible and resistant strains for clarithromycin (46.9+/-32.3 vs 45.7+/-30.6; P=0.8), metronidazole (46.4+/-29.6 vs 47.4+/-37.9; P=0.8), and levofloxacin (45.0+/-30.2 vs 54.2+/-38.4; P=0.08). Likewise, comparable DOB values were observed between susceptible and multidrug-resistant strains (45.4+/-29.6 vs 54.8+/-44.8; P=0.1). In conclusion, our data failed to find a significant correlation between UBT values and H. pylori antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093375     DOI: 10.1099/jmm.0.018077-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  8 in total

1.  Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.

Authors:  Alba A Trespalacios; William Otero; Jorge E Caminos; Marcela M Mercado; Jenny Avila; Liliana E Rosero; Azucena Arévalo; Raúl A Poutou-Piñales; David Y Graham
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

Review 2.  Innovative Perspectives of Integrated Chinese Medicine on H. pylori.

Authors:  Hui Ye; Zong-Ming Shi; Yao Chen; Jing Yu; Xue-Zhi Zhang
Journal:  Chin J Integr Med       Date:  2018-06-08       Impact factor: 1.978

Review 3.  Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis.

Authors:  Giuseppe Losurdo; Rossella Cubisino; Michele Barone; Mariabeatrice Principi; Gioacchino Leandro; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742

Review 4.  Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches.

Authors:  Amin Talebi Bezmin Abadi
Journal:  J Pathog       Date:  2018-05-22

5.  Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study.

Authors:  Jin Young Yoon; Jae Myung Cha; Seong Soo Hong; Hyung Kyung Kim; Min Seob Kwak; Jung Won Jeon; Hyun Phil Shin
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 6.  Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness.

Authors:  Enzo Ierardi; Giuseppe Losurdo; Rosa Federica La Fortezza; Mariabeatrice Principi; Michele Barone; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

Review 7.  Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.

Authors:  Hyelnaya Cletus Sharndama; Ifeanyi Elibe Mba
Journal:  Braz J Microbiol       Date:  2022-01-06       Impact factor: 2.476

8.  Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study.

Authors:  Sreenivasulu Puram; Hyung Chae Suh; Seung Un Kim; Bharathi Bethapudi; Joshua Allan Joseph; Amit Agarwal; Venkateswarlu Kudiganti
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.